Donation

Dr. Joseph Mikhael and Yelak Biru discuss myeloma clinical trials at the IMF Patient & Family Seminar in Los Angeles, CA
Clinical Trials and Treatments
December 5
Progress in the Field of Myeloma: the Past, the Present, and the Future
Team of Medical Research Scientists Work in a Lab
Clinical Trials and Treatments
August 29
2024 ASCO and EHA Meetings Feature Four Phase III Clinical Trials and More! 
Scientist consults clipboard to analyze blood samples
Clinical Trials and Treatments
April 18
The State of Myeloma in 2024
young African American female doctor studying in a lab
Clinical Trials and Treatments
February 29
Research at ASH 2023: Health Equity and the Patient Experience
Closeup of bispecific antibody
Clinical Trials and Treatments
November 23
ELREXFIO (elranatamab-bcmm) Approved By FDA
Closeup of bispecific antibody
Clinical Trials and Treatments
November 16
TALVEY (talquetamab-tgvs) Approved By FDA
Closeup of scientist taking blood sample in lab
Clinical Trials and Treatments
August 10
Is It Time to Bring the CAR Home Early?
Scientists brainstorming a project
Clinical Trials and Treatments
February 27
Research on Myeloma Disparities
myeloma medical technology
Clinical Trials and Treatments
December 12
Myeloma Treatment Options in Early Relapse
Tecvali is now FDA approved for use in multiple myeloma.
Clinical Trials and Treatments
October 25
TECVAYLI (teclistamab-cqyv) Receives FDA Approval
Masked scientist views research on lab computer
Clinical Trials and Treatments
May 5
Overview of Key ASCO and EHA Abstracts
Masked researcher analyzes sample under lab microscope
Clinical Trials and Treatments
May 5
Bispecific Antibodies: The Next Wave of Immunotherapy in Myeloma is Coming
Subscribe to Clinical Trials and Treatments

Give Where Most Needed

Learn More